• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Pancreatic acinar cell carcinoma: A comprehensive review

    2022-11-05 03:45:42LuisFernandoCalimanoRamirezTaherDaoudDheerajReddyGopireddyAjaykumarMoraniRebeccaWatersKazimGumusAlbertRussellKlekersPriyaBhosaleMayurVirarkar
    World Journal of Gastroenterology 2022年40期

    Luis Fernando Calimano-Ramirez,Taher Daoud, Dheeraj Reddy Gopireddy,Ajaykumar C Morani,Rebecca Waters, Kazim Gumus,Albert Russell Klekers,Priya R Bhosale,Mayur K Virarkar

    Abstract Acinar cell carcinoma (ACC) is a rare pancreatic malignancy with distinctive clinical, molecular, and morphological features. The long-term survival of ACC patients is substantially superior to that of pancreatic adenocarcinoma patients.As there are no significant patient series about ACCs, our understanding of this illness is mainly based on case reports and limited patient series. Surgical resection is the treatment of choice for patients with the disease restricted to one organ; however, with recent breakthroughs in precision medicine, medicines targeting the one-of-a-kind molecular profile of ACC are on the horizon. There are no standard treatment protocols available for people in which a total surgical resection to cure the condition is not possible. As a result of shared genetic alterations, ACCs are chemosensitive to agents with activity against pancreatic adenocarcinomas and colorectal carcinomas. The role of neoadjuvant or adjuvant chemoradiotherapy has not been established. This article aims to do a comprehensive literature study and present the most recent information on acinar cell cancer.

    Key Words: Acinar cell carcinoma; Pancreas; Imaging; Immunohistochemical stains;Molecular features; Surgery; Chemotherapy

    INTRODUCTION

    The rising prevalence of abdominal imaging has resulted in an uptick in historically rare pancreatic cancer cases. The exocrine pancreas primarily comprises acinar and ductal cells[1]. Although acinar tissue accounts for most of the pancreatic organ, pancreatic neoplasms that mainly exhibit acinar differentiation are rare. The expression of various pancreatic enzymes, such as chymotrypsin, trypsin, and lipase, leads to acinar differentiation in the exocrine pancreas[1]. Most acinar neoplasms are solid,malignant, and not well-recognized[2]. Acinar cell cystadenoma is the sole benign acinar neoplasm documented; uncommon benign cystic, malignant cystic, and mixed carcinomas also exist.

    Acinar cell carcinoma (ACC) of the pancreas is a rare, malignant tumor composed of cells with morphological resemblance to acinar cells and with evidence of exocrine enzyme synthesis by the neoplastic cells, accounting for 1%-2% of all pancreatic neoplasms[2-4]. ACC of the pancreas is a highgrade malignancy with no apparent site preference; it can occur in any section of the pancreas, but the head is the most common location.

    Currently, there is no definitive course of treatment for ACC; however, vigorous surgical resection with negative margins has been linked to improved long-term survival[5]. Particularly with the use of computerized tomography (CT) and magnetic resonance imaging (MRI), as well as with the confirmation of fine needle aspiration (FNA) biopsies, early recognition and diagnosis are of particular relevance. Knowledge of these lesions' morphologic and immunohistochemical characteristics is also essential for a precise clinical diagnosis. In addition, extensive molecular analyses of acinar neoplasms have identified genomic alterations that may be amenable to specific therapies, thereby increasing the likelihood of widespread clinical molecular testing of these tumors.

    This article aims to do a comprehensive literature study and present the most recent information on acinar cell cancer.

    EPIDEMIOLOGY

    ACC of the pancreas accounts for 1%-2% of all adult exocrine pancreatic neoplasms and 15% of pediatric neoplasms. ACC occurs most frequently in white males and is usually bimodal in age, with peaks in childhood at 8-15 years of age and adulthood with a peak incidence at 60 and is rare between the ages of 20 and 40. ACC has a 3.6 male-to-female ratio. No known racial relationships exist[1,6,7].

    CLINICAL FEATURES

    Most ACC s exhibit vague symptoms, which include weight loss (45%), abdominal pain (60%), back pain (50%), nausea and vomiting (20%), melena (12%), weakness, anorexia, and diarrhea (8%) are typical non-specific symptoms of ACC[8,9]. In distinction to ductal adenocarcinoma, ACC infrequently obstructs the bile duct and causes jaundice only in 12% of patients. ACC causes a mass effect and displaces those organs but does not infiltrate[10].

    Some patients experience paraneoplastic disease known as "Schmid's Triad" or lipase hypersecretion syndrome due to increased lipase levels reaching over 10000 U/dL[11,12]. Elevated lipase may be the first sign of ACC. Patients may present with multiple nodular foci of subcutaneous fat necrosis,polyarthralgia may occur due to fat necrosis in the cancellous bone, and may have peripheral blood eosinophilia[13,14]. On imaging, fat necrosis within the bone can appear as a focal area of sclerosis.Paraneoplastic syndrome may occur following tumor recurrence. Most patients have hepatic metastases at presentation; however, some may present with only a bulky pancreatic mass. The serum lipase levels may normalize after surgical resection of the tumor, and patients may have symptomatic relief. Lipase may be used as a tumor marker in these patients. Alpha-fetoprotein (AFP) blood levels can be elevated in young patients[15].

    MACROSCOPY (GROSS FEATURES)

    On FNA, an abundance of cells with fluctuating degrees of acinar differentiation but no endocrine or ductal cells are seen. The aspirates consist primarily of cohesive fragments creating acini, cellular cords,or solid nests of neoplastic epithelium, composed of clusters of uniform cells with smoothly contoured,eccentric nuclei containing one or two prominent nuclei nucleoli[16,17].

    ACCs can occur in any region of the pancreas and, on average, are 10 to 11 cm in size at the time of diagnosis[18-20]. The tumors are well circumscribed and have a soft, fleshy, tan to red appearance[2].They occasionally exhibit lobulated appearances, necrosis, and cystic degeneration[20]. On occasion, the neoplasm is found attached to the surface of the pancreas. Involvement of the duct system by ACCs can sometimes be observed grossly as polypoid or fingerlike projections extending from the primary tumor mass toward the duct[21].

    PATHOLOGY

    ACCs are cellular neoplasms with minimal stroma on microscopic examination. Multiple architectural patterns, including acinar (Figure 1A), solid (Figure 1B), glandular (Figure 1C), and trabecular(Figure 1D), can be observed. Solid and acinar patterns are the most prevalent. The acinar pattern is characterized by structures resembling normal acini, with small lumina and cells arranged in a monolayer with basally located nuclei. Large sheets of cells depict the solid pattern without lumina.Acinar structures with the dilated lumen characterize the less common granular pattern. The trabecular pattern, which resembles the architecture of well-differentiated neuroendocrine tumors, consists of more pronounced palisading with thinner, interlacing ribbons of cells. Multiple architectural patterns are visible within a single tumor.

    IMMUNOHISTOCHEMISTRY

    The immunohistochemical labeling of enzyme production from pancreatic cells aids in confirming the diagnosis of ACC (Table 1). There are commercially available antibodies for chymotrypsin, trypsin,lipase, and amylase, with the first three being the most frequently used in clinical settings (Figure 1E).These enzymes exhibit varying degrees of specificity and sensitivity. In approximately 95% of cases,trypsin and chymotrypsin reactivity can be demonstrated, and this combination is reportedly the most sensitive for diagnosing ACC[10,22].

    ACC is also positive for CK8 and CK18, and as a result, they will label for AE1/AE3 and CAM5.2.CK7 (Figure 1F) and CK19, which are usually expressed in ductal adenocarcinomas, are generally missing in ACC but may be expressed in a subgroup of ACCs[15,23]. Focal labeling for chromogranin and synaptophysin is observed in a substantial proportion of ACCs, displaying the need to assess with further clear-cut acinar markers, especially in small samples, to avoid misidentifying an ACC as a neuroendocrine tumor or mixed acinar-neuroendocrine differentiation[10,24,25]. Recent research on histological and cytological samples has proven that the monoclonal antibody directed against the COOH-terminal region of the BCL10 protein, which identifies the COOH-terminal portion of CEL, is a highly specific and sensitive approach for detecting ACCs[26,27].

    MOLECULAR FEATURES

    The genetic alterations driving ACC have been thoroughly characterized and sequenced. The outcomes of these studies have emphasized the diversity of modified genes and pathways among various tumors,as well as the marked genomic instability in a subset of instances, including at the base pairs and chromosomes level. Several studies analyzed ACC for mutations in gene changed in pancreatic ductal adenocarcinoma (PDAC), the most prevalent subtype of pancreatic cancer, before the wide availability of whole genome and exome. Several of these studies reported uncommon mutations inTP53,KRAS,andSMAD4, in addition to the unusual loss of SMAD4 expression in acinar neoplasms, while others reported no modifications in these genes[28-33]. In these studies, the most prevalent ACC mutationsaffected WNT signalings, such as mutations in APC that rendered inactive and mutations in CTNNB1 that rendered it active; these alterations were found in roughly 20% of ACCs[30]. Recent sequencing studies of the entire exome have highlighted the diversity of mutated genes in the ACC[34,35]. Several other studies have shown substantial chromosomal gains and losses in ACCs and altered regions in various carcinomas; nevertheless, the target genes (if any) in these regions have not been detected[29,30,36,37].

    Table 1 Immunohistochemical profile from the differential diagnosis

    Figure 1 Histopathological patterns. A: Acinar cell carcinoma with the predominant acinar pattern. The acinar pattern is characterized by structures resembling normal acini, with small lumina and cells arranged in a monolayer with basally located nuclei; B: Acinar cell carcinoma with the predominant glandular pattern. Acinar structures with dilated lumina characterize the glandular pattern; C: Acinar cell carcinoma with the predominant trabecular pattern. The trabecular pattern is characterized by ribbons of cells resembling those of pancreatic neuroendocrine tumors; D: Acinar cell carcinoma with a predominant solid pattern. Large sheets of cells characterize the solid pattern without lumina; E: Acinar cell carcinoma, immunohistochemical staining for trypsin; F: Acinar cell carcinoma, immunohistochemical staining for cytokeratin 7.

    Multiple potentially targetable genetic alterations in pancreatic ACC have been identified. A subset of cases exhibits genomic instability due to mutations in genes involved in DNA repairs, such asATM,BRCA1,BRCA2,PALB2, andMSH2[34,35]. According to various studies, microsatellite instability has been documented in fluctuating proportions of ACC, ranging from 7% to 14%[30,35,38]. Also, platinum agents and PARP inhibitors treat tumors with mutations in BRCA pathway genes[39,40]. Even though it has not yet been proven in major clinical trials, preliminary findings indicate that tumors with BRAF fusions react to MEK inhibitors, providing ACC with targeted therapy[41-43]. In a subgroup of ACCs,MYC abnormalities, including chromosome 8 polysomy and gene amplification, have been identified recently[44].

    Table 2 Summary of pertinent differential diagnostic features

    DIAGNOSIS

    Laboratory analysis

    Besides an increase in serum lipase levels associated with the syndrome of lipase hypersecretion, serum tumor markers are not consistently elevated in ACC. Even in the absence of lipase hypersecretion syndrome, lipase might be high. There have been numerous AFP increases, especially in younger patients[2]. Typically, Serum tumor markers such as carbohydrate antigen 19-9, alpha-fetoprotein, and carcinoembryonic antigen are expressed.

    Radiological features (imaging)

    In recent years, the incidence of uncommon pancreatic cancers has grown, likely due to the increased use of cross-sectional imaging[45]. In most instances, pancreatic cancers are incidentally found by CT.MRI is often used as a secondary test for further characterization. ACC of the pancreas is a well-defined,primarily oval or round exophytic mass in cross-sectional imaging[46,47]. Rarely have cystic variations been described. Typically, it manifests as a dense, largely solid tumor devoid of noticeable cystic alterations[46,48]. One-third of patients may exhibit calcifications, and the majority of the tumor increases constantly, but less so than the adjacent pancreatic parenchyma[49]. The tumor displays heterogeneous enhancement after intravenous infusion of contrast material[46]. Other studies also concluded that when confronted with a large mass with an ovoid shape, exophytic, well-circumscribed arising from the pancreas, with slight and persistent enhancement after contrast administration, and without appreciable biliary or pancreatic dilation, the diagnosis of ACC should be considered[18,47,50].Another study stated that MRI is better than CT for identifying tumor margination, intratumoral bleeding, tissue invasion, and ductal dilation[51]. On the other hand, CT is more sensitive to detecting central calcification and is commonly utilized due to its accessibility and quickness[50,51]. CT and MRI accurately depict most ACC imaging characteristics, and the two modalities correlate well[51].

    Differential diagnosis

    Pancreatic endocrine neoplasms that are well-differentiated, solid pseudopapillary neoplasms (SPNs),mixed acinar neoplasms, pancreatoblastoma (PBL), and PDACs should be included in the differential diagnosis (Table 2). Well-differentiated endocrine neoplasm, also commonly known as pancreatic neuroendocrine tumors (PanNET), is the entity most widely confused and misdiagnosed[2]. Both neoplasms typically contain a high number of cells and little amount of stroma, are capable of forming cell sheets and can consist of medium-sized, spherical, monomorphic cells with a microglandular or solid pattern of growth[2]. In addition, the red cytoplasmic zymogen and neurosecretory granules from ACC and PanNETs, respectively, are similar with appropriate differentiation. PanNETs are associated with a more favorable prognosis, making differentiation crucial. ACCs are distinguished from PanNETs by their primary acinar development, cytoplasmic granulation, basally oriented nuclei, and individual conspicuous nucleoli. However, hyalinized stroma, plasmacytoid cell appearance, and a "salt and pepper" chromatin pattern are indicative of PanNET[6]. Immunohistochemistry is advantageous, but it must be utilized with care. Using general neuroendocrine markers such as synaptophysin and chromogranin A alone may be unsafe because several ACCs contain neuroendocrine cells, which are particularly abundant in 30% of cases, as stated before[10,24]. Therefore, the demonstration of acinar cell products is mandatory if an ACC is suspected.

    SPNs present as massive, dense pancreatic masses that are clinically identical to ACC; however, SPNs virtually entirely affect women of young age[52]. Cytological smears are characterized by delicately branched vasculature with lightly adherent cells generating pseudopapillary structures, a homogenous population of microscopic cells with cuboidal formation, and a unique hyaline myxoid matrix[52].Additionally, cytoplasmic hyaline globules are occasionally visible. Moreover, the SPNs nuclei are often normochromic, with numerous indentations, and lack the conspicuous nucleoli found in acinar cells[53]. Typically, SPNs exhibit nuclear immunoreactivity for β-catenin and high expression of CD10,which are also detectable in roughly 10% and 60% of ACCs, respectively. As a result, these two markers must be utilized in conjunction with markers specific to acinar cells, such as trypsin and BCL10[53-55].

    PBL is another entity with stroma-poor acinar differentiation that must be evaluated in the differential diagnosis. Similar to ACCs, upon the appearance, PBLs are typically large, with an average size of 10 cm ranging from 1.5 to 20 cm[56]. This uncommon tumor shares nearly all of the cytologic and clinical characteristics of ACC, notably in the population of younger age, where it is frequently observed[2,57]. Cytologically, the neoplasms may be indistinguishable because they both display a predominant acinar-cell differentiation[2]. Heterologous components and squamous nests, such as osseous and cartilage development, characterize PBL[2]. In addition to immunochemistry and clinicopathologic data,the heterogeneous cytologic elements of the types of the tumor-cell present, including a combination of squamoid, mesenchymal, and glandular cells, are a general clue to diagnosing PBL[58]. Histologically,the presence of squamoid nests in PBL is the distinguishing characteristic of the two entities.

    ACCs typically lack the characteristic cytomorphologic features of PDACs, allowing these two tumors to be distinguished easily. PDACs typically exhibit "drunk honeycomb" and "tombstone cells"arrangements alongside nuclear heterogeneity and nuclear silhouette abnormalities[59]. This is in contrast to the relatively homogeneous polygonal cells of ACCs, which are arranged in threedimensional arrays and tissue fragments[1]. ACCs lack the large desmoplastic stroma that describes PDACs and display an overall solid and acinar architecture, whereas PDACs feature a prominent desmoplastic stroma[10,59,60].

    STAGING FOR ACINAR PANCREATIC CARCINOMA

    The staging system for acinar pancreatic cancer is undergoing continuous development. Clinical staging is determined by resectability, which is heavily impacted by surgical expertise. The agreed guidelines for the resectability of surgical procedures continue to be refined (e.g., National Comprehensive Cancer Network, MD Anderson Cancer Center, American Hepato-Pancreato-Biliary Association, and International Hepato-Pancreato-Biliary Association). Traditionally, they are categorized as resectable,borderline resectable, locally progressed, and metastatic. To begin with, resectable tumors lack vascular involvement. Next, the borderline resectable tumors involve vascular, local structures, or other signs indicating a high risk of R1 resection. Local invasions (particularly vascular involvement) prevent surgical intervention for locally progressed malignancies. Lastly, metastatic cancer has spread to other organs beyond the main pancreatic tumor. The American Joint Committee on Cancer (AJCC) has classified staging by TNM (tumor, node, metastasis) classification using the consensus guidelines for resectability (Table 3 and Figure 2)[61]. Imaging cases with different AJCC TNM staging were added in chronological order (Figures 3 - 7) to appreciate the differences in changes.

    PROGNOSIS, FACTORS OF PREDICTION, SPREAD, AND METASTASES

    ACCs are exceptionally malignant neoplasms; relatively 50% of patients have metastasis during diagnosis[62]. Initial studies indicate that the prognosis for ACCs is better than that for ductal carcinomas but worse than that for PanNETs[5,63,64]. Previous research using population-based cancer databases and epidemiological methods indicated that individuals diagnosed with ACCs have a median overall survival time of roughly 47 mo for patients with localized disease and 14 mo for patients with metastatic disease, with a 5-year survival rate ranging from 36.2% to 72.8% for resected cancers[5,64,65].A recent study shows that ACC has a better prognosis than adenocarcinoma. They found that the prognosis was deteriorating with a decrease of 25% in a 5-year survival rate to previously reported rates[66]. However, data from a few studies published and anecdotal reports hint that some patients with ACCs have a greater survival rate than expected; unfortunately, no parameters are available to identify this group of patients[67,68].

    Figure 2 American Joint Committee on Cancer 8th Edition cancer staging for exocrine pancreatic tumor such as pancreatic acinar cell carcinoma. A: Stage 0 (TNM: Tis, N0, M0). Tis = Carcinoma in situ. N0 = No regional lymph node metastases. M0 = No distant metastasis; B: Stage IA (TNM: T1,N0, M0). T1 = Tumor ≤ 2 cm in greatest dimension. N0 = No regional lymph node metastases. M0 = No distant metastasis; C: Stage IB (TNM: T2, N0, M0). T2 =Tumor > 2 cm and ≤ 4 cm in greatest dimension. N0 = No regional lymph node metastases. M0 = No distant metastasis; D: Stage IIA (TNM: T3, N0, M0). T3 = Tumor> 4 cm in greatest dimension. N0 = No regional lymph node metastases. M0 = No distant metastasis; E: Stage IIB (TNM: T 1/2/3, N1, M0). T 1/2/3 = Tumor ≤ 2 cm >4 cm in greatest dimension. N1 = Metastasis in one to three regional lymph nodes. M0 = No distant metastasis; F: Stage III (TNM: T 1/2/3, N2, M0 or T4, Any N, M0).T 1/2/3 = Tumor ≤ 2 cm > 4 cm in greatest dimension. N2 = Metastasis in four or more regional lymph nodes. T4 = Tumor involves celiac axis, superior mesenteric artery, and common hepatic artery, regardless of size; G: Stage IV (TNM: Any T, Any N, M1). M1 = Distant metastasis. T = Primary tumor; N = Regional lymph node;M = Distant metastasis.

    Figure 3 Stage IA (T1, N0, M0). A 77-year-old male patient with acinar cell carcinoma. Axial post-contrast portal-venous phase computed tomography image shows a solid mass (short arrows) measuring 1.8 cm × 1.6 cm and involving the region of the pancreatic head/body. Incidental findings are calcifications seen throughout the pancreas (likely related to changes in chronic pancreatitis) and mild dilatation of the biliary tree with pneumobilia (long arrow).

    Rarely do patients with ACC are diagnose with lung, cervical lymph nodes, and ovary metastases.Metastatic illness is typically detected in regional lymph nodes and the liver[69]. Patients presenting as their first disease symptom with distant metastases are infrequent. It has been proposed that ACCs in patients younger than 20 may be less aggressive than in adults[10]. The most significant prognostic indicator is the tumor stage, with patients without lymph nodes or distant metastases having a better prognosis[5,70]. In addition, a poor prognosis is also associated with being male, being over 60, and having a tumor larger than 10 cm[5].

    TREATMENT

    Current, surgical, radiotherapeutic, and chemotherapeutic treatments used for PDAC are typically used to treat ACC (Table 4). Surgery is regarded as the optimal treatment modality for ACCs that areregionally circumscribed and resectable. Holenet al[8]found that median survival for surgically resected cases was 36 mo, compared to 14 mo for those without surgical resection[8]. Another systematic research by Glazeret al[71]indicated that the total median survival rate for patients with ACC who had resection was approximately 47 mo[71]. More aggressive therapeutic regimens must be sought when surgery is unavailable for locally advanced and metastatic diseases.

    Table 3 American Joint Committee on Cancer 8th Edition cancer staging for exocrine pancreatic tumor such as pancreatic acinar cell carcinoma

    large blood vessels2 Any N NX = Regional lymph nodes cannot be assessed N0 = No regional lymph node metastases N1 = Metastasis in one to three regional lymph nodes N2 = Metastasis in four or more regional lymph nodes M0 No distant metastasis IV Any T TX = Primary tumor cannot be assessed T0 = No evidence of primary tumor Tis = Carcinoma in situ1 T1 = Tumor is ≤ 2 cm in any direction T1a = Tumor is ≤ 0.5 cm in any direction T1b = Tumor is > 0.5 cm and < 1 cm in any direction T1c = Tumor is 1-2 cm in any direction T2 = Tumor is > 2 cm and ≤ 4 cm in any direction T3 = Tumor is > 4 cm in any direction T4 = Regardless of tumor size, the cancer has grown outside the pancreas, into the nearby large blood vessels2 Any N NX = Regional lymph nodes cannot be assessed N0 = No regional lymph node metastases N1 = Metastasis in one to three regional lymph nodes N2 = Metastasis in four or more regional lymph nodes M1 Distant metastasis 1Included in this category are high-grade pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm with high-grade dysplasia,intraductal tubulopapillary neoplasm with high-grade dysplasia, and mucinous cystic neoplasm with high-grade dysplasia.2Celiac axis, superior mesenteric artery, and/or common hepatic artery are involved.T: Primary tumor; N: Regional lymph node; M: Distant metastasis.

    Table 4 Acinar cell carcinoma treatment options

    Figure 4 Stage IB (T2, N0, M0). An 89-year-old male patient with acinar cell carcinoma. Axial post-contrast computed tomography arterial phase image shows a large mass in the body of the pancreas (arrow) measuring 3.3 cm × 3 cm. No regional adenopathy is identified.

    Figure 5 Stage IIA (T3, N0, M0). A 66-year-old patient with acinar cell carcinoma. Axial post-contrast computed tomography image in the arterial phase shows a solid lobulated mass measuring 6.5 cm × 5.4 cm arising from the tail of the pancreas (arrow). The mass is heterogeneous in density with areas of low-density and solid-enhancing areas. No regional or distant lymphadenopathy was detected.

    Due to the rareness of ACC and the absence of sufficient randomized trials comparing different treatment approaches, the role of adjuvant therapy remains debatable. Table 5 enlists characteristics of studies on various regimes used for treating ACC. In a study at Memorial Sloan-Kettering Cancer Center, systemic chemotherapy for ACC was determined to be ineffective[8]. Following surgical resection, there are no clear treatment guidelines, and most adjuvant therapies are individualized with variable response rates. Lack of prospective data to create therapy guidelines and genetic variation in theAPCgene/β-catenin pathway observed in pancreatic acinar cells, ACC patients are frequently treated with chemotherapeutic agents known to be active against PDAC or colorectal cancer[72]. Most study participants received combination chemotherapy protocols based on gemcitabine or fluoropyrimidine[11,73]. If the ACC cannot be resected, the patient should undergo neoadjuvant or palliative 5-FU chemotherapy[70,74]. Combination fluoropyrimidine-based chemotherapies have increased disease control rates[8,11,73,75-77]. Glazeret al[71]systematic review showed that patients with a high-performance status typically receive folinic acid/fluorouracil/oxaliplatin or folinic acid/fluorouracil/irinotecan. In contrast, patients with a lower performance status typically receive gemcitabine/protein-bound paclitaxel[71].

    Conventional fractionation and hypofractionated stereotactic body radiotherapy are used to "downstage" or convert a borderline resectable tumor to one that is resectable[73]. Patients who could potentially benefit from resection can be identified through the absence of ACC development following neoadjuvant radiotherapy. Several studies reported a "major response" rate from 25% to 35% of these individuals[8,11].

    Figure 6 Stage IIB (T3, N1, M0). A 61-year-old patient with acinar cell carcinoma. A: Axial post-contrast computed tomography (CT) image in the portovenous phase shows an infiltrative mass arising from the pancreatic body and tail (arrow); B: axial post-contrast CT images in the portovenous phase shows an enlarged mesenteric lymph node (arrow) measuring 2.6 cm × 1.2 cm; C: Axial positron emission tomography/CT image in the portovenous phase shows hypermetabolic pancreatic body and tail mass (arrow); D: Axial post-contrast CT images in the portovenous phase shows hypermetabolic enlarged mesenteric lymph node (arrow).Pathology of the mass revealed Acinar cell carcinoma with a metastatic mesenteric lymph node.

    Figure 7 Stage IV. A 64-year-old patient with acinar cell carcinoma. A: Axial post-contrast image port venous phase shows a pancreatic head mass measuring about 3.2 cm × 2.8 cm (arrow); B: Axial post-contrast image port venous phase shows multiple bilobar variable-sized hepatic metastatic lesions (arrows). An incidental finding is an area of splenic infarction (asterisk in image A).

    CONCLUSION

    Pancreatic acinar neoplasms are a molecularly and morphologically heterogeneous group of diseases far less prevalent than ductal neoplasms. Due to its low surgical resectability, high rate of recurrence, and high frequency of metastases at diagnosis, pancreatic ACC has been regarded as cancer with a poor prognosis. At least a subset of the neoplastic cells exhibits acinar differentiation, as defined morphologically (granular cytoplasm, single prominent nucleoli) or immunohistochemically. The molecular system underlying the advancement of ACCs has been elucidated, revealing potentially targetable mutations that offer optimism for developing additional curative options. ACC usually appears as a bulky mass that does not obstruct the pancreatic or bile duct and does not cause jaundice. Elevated lipase levels, subcutaneous nodules, and the presence of bone infarct should help clinch a diagnosis of ACC. Also, these tumors have large lymph nodes at presentation. In the future, molecular diagnostics to detect lesions susceptible to targeted therapy will likely play an important role in patient care.

    Table 5 Characteristics of studies on various acinar cell carcinoma treatment regimes

    ACC: Acinar cell carcinoma; PDAC: Pancreatic ductal adenocarcinoma; RT: Radiotherapy; 5-FU: 5-fluorouracil; SOX: S1 + Oxaliplatin; AG: Albumin-bound paclitaxel + gemcitabine; FOLFIRNOX: 5-FU + oxaliplatin + leucovorin + irinotecan.

    ACKNOWLEDGEMENTS

    We thank Kelly Kage for the beautiful illustrations.

    FOOTNOTES

    Author contributions:All authors equally contributed to this paper with the conception and design of the study,literature review and analysis, drafting, critical revision, editing, and approval of the final version.

    Conflict-of-interest statement:All the authors report no relevant conflicts of interest for this article.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:United States

    ORCID number:Luis Fernando Calimano-Ramirez 0000-0003-2599-3179; Taher Daoud 0000-0001-9161-1314; Dheeraj Reddy Gopireddy 0000-0001-8441-7804; Ajaykumar C Morani 0000-0002-2936-0291; Rebecca Waters 0000-0002-8163-7497; Kazim Gumus 0000-0002-1450-6868; Albert Russell Klekers 0000-0003-1202-7369; Priya R Bhosale 0000-0003-4014-4941; Mayur K Virarkar 0000-0002-5825-3102.

    S-Editor:Fan JR

    L-Editor:A

    P-Editor:Fan JR

    国产91精品成人一区二区三区| aaaaa片日本免费| 亚洲国产精品sss在线观看 | 亚洲熟女精品中文字幕| 日本精品一区二区三区蜜桃| 国产深夜福利视频在线观看| 老司机亚洲免费影院| 国产aⅴ精品一区二区三区波| 久久九九热精品免费| 亚洲熟妇中文字幕五十中出 | 欧美性长视频在线观看| 午夜久久久在线观看| 久久久国产成人免费| 欧美日韩乱码在线| 18禁国产床啪视频网站| 激情在线观看视频在线高清 | 女人高潮潮喷娇喘18禁视频| 一本综合久久免费| 女人被狂操c到高潮| 一级片免费观看大全| 99在线人妻在线中文字幕 | 国产精品成人在线| 日韩三级视频一区二区三区| 人人妻,人人澡人人爽秒播| 岛国在线观看网站| 亚洲色图综合在线观看| 欧美丝袜亚洲另类 | 9色porny在线观看| 国产熟女午夜一区二区三区| 日韩欧美免费精品| 宅男免费午夜| 91成人精品电影| 久久香蕉精品热| 黑人操中国人逼视频| av网站在线播放免费| 中亚洲国语对白在线视频| 亚洲精品美女久久av网站| 日韩成人在线观看一区二区三区| 国产精品亚洲一级av第二区| 国精品久久久久久国模美| 两人在一起打扑克的视频| 久久久久久久久久久久大奶| 亚洲久久久国产精品| 在线视频色国产色| 精品一区二区三区视频在线观看免费 | 成人精品一区二区免费| 777米奇影视久久| 久久久国产成人免费| 久久久久久久精品吃奶| 99精品欧美一区二区三区四区| 精品亚洲成a人片在线观看| 成人特级黄色片久久久久久久| 高清欧美精品videossex| 欧美大码av| 欧美丝袜亚洲另类 | 热re99久久国产66热| 777米奇影视久久| 男人操女人黄网站| 满18在线观看网站| 欧美激情极品国产一区二区三区| av在线播放免费不卡| 妹子高潮喷水视频| 色综合婷婷激情| 亚洲精品国产色婷婷电影| 亚洲人成伊人成综合网2020| 久久天躁狠狠躁夜夜2o2o| 久久人人爽av亚洲精品天堂| 制服诱惑二区| 久久久久国内视频| 啪啪无遮挡十八禁网站| 视频区欧美日本亚洲| 精品乱码久久久久久99久播| 日本五十路高清| 精品国产亚洲在线| 成年人午夜在线观看视频| 美女福利国产在线| 两个人看的免费小视频| 成人三级做爰电影| 后天国语完整版免费观看| 叶爱在线成人免费视频播放| 午夜福利,免费看| 精品视频人人做人人爽| 好男人电影高清在线观看| 97人妻天天添夜夜摸| 国产1区2区3区精品| 成熟少妇高潮喷水视频| 欧美黄色淫秽网站| 香蕉国产在线看| 亚洲av熟女| 极品教师在线免费播放| 日韩三级视频一区二区三区| 欧美激情 高清一区二区三区| 国产淫语在线视频| 免费在线观看影片大全网站| 午夜福利影视在线免费观看| 夜夜躁狠狠躁天天躁| 丰满人妻熟妇乱又伦精品不卡| 亚洲精品乱久久久久久| 欧美色视频一区免费| 亚洲av熟女| 精品久久久久久久毛片微露脸| www.999成人在线观看| 18禁国产床啪视频网站| 欧美黑人精品巨大| 国产男靠女视频免费网站| 天堂俺去俺来也www色官网| 亚洲va日本ⅴa欧美va伊人久久| 黑人操中国人逼视频| 国产精品电影一区二区三区 | www.自偷自拍.com| 在线观看www视频免费| 亚洲中文字幕日韩| 黑人巨大精品欧美一区二区mp4| 九色亚洲精品在线播放| 老司机深夜福利视频在线观看| 色播在线永久视频| 国产人伦9x9x在线观看| 欧美成人免费av一区二区三区 | 黄片播放在线免费| 欧美精品av麻豆av| 国产亚洲欧美精品永久| 后天国语完整版免费观看| 国产黄色免费在线视频| 亚洲五月天丁香| 99国产精品一区二区蜜桃av | 91大片在线观看| 欧美精品av麻豆av| 亚洲精品国产色婷婷电影| 美女扒开内裤让男人捅视频| 国产国语露脸激情在线看| 国产精华一区二区三区| 十八禁人妻一区二区| 一级,二级,三级黄色视频| 黄频高清免费视频| videosex国产| 99国产精品免费福利视频| 人妻一区二区av| 在线免费观看的www视频| 国产免费av片在线观看野外av| 国产日韩欧美亚洲二区| 久久久久久人人人人人| 午夜视频精品福利| 自线自在国产av| 欧美+亚洲+日韩+国产| 亚洲专区中文字幕在线| 欧美日韩黄片免| 国产精品免费视频内射| 手机成人av网站| 午夜激情av网站| 九色亚洲精品在线播放| 手机成人av网站| av免费在线观看网站| 亚洲一区二区三区不卡视频| 欧美日韩国产mv在线观看视频| 精品国产国语对白av| 王馨瑶露胸无遮挡在线观看| 亚洲色图综合在线观看| xxxhd国产人妻xxx| 99香蕉大伊视频| 亚洲av熟女| 电影成人av| 啪啪无遮挡十八禁网站| 日本撒尿小便嘘嘘汇集6| 久久精品aⅴ一区二区三区四区| 久久狼人影院| 成年动漫av网址| 国产91精品成人一区二区三区| 精品人妻在线不人妻| 欧美老熟妇乱子伦牲交| 国产高清激情床上av| 一进一出好大好爽视频| 宅男免费午夜| 亚洲,欧美精品.| 亚洲成人国产一区在线观看| 黄片小视频在线播放| 亚洲,欧美精品.| www.999成人在线观看| 热99久久久久精品小说推荐| 宅男免费午夜| 亚洲熟妇中文字幕五十中出 | 国产野战对白在线观看| 亚洲国产毛片av蜜桃av| 两个人免费观看高清视频| 成年动漫av网址| 国产精品久久久人人做人人爽| 免费在线观看完整版高清| 91精品三级在线观看| 亚洲熟妇中文字幕五十中出 | 久久狼人影院| 国产xxxxx性猛交| 99re在线观看精品视频| 午夜福利乱码中文字幕| 宅男免费午夜| 国产精品影院久久| 动漫黄色视频在线观看| 看片在线看免费视频| 一级毛片高清免费大全| 在线国产一区二区在线| 天天躁日日躁夜夜躁夜夜| 国产精品久久久久成人av| 一边摸一边抽搐一进一出视频| 色老头精品视频在线观看| 又紧又爽又黄一区二区| 国产成人欧美| 一级黄色大片毛片| 一区二区三区激情视频| 成人av一区二区三区在线看| 新久久久久国产一级毛片| 精品视频人人做人人爽| 久久精品国产清高在天天线| 国产精品二区激情视频| 国产午夜精品久久久久久| 国产欧美亚洲国产| 免费女性裸体啪啪无遮挡网站| 老鸭窝网址在线观看| 免费看十八禁软件| 欧美精品一区二区免费开放| 国产麻豆69| 欧美中文综合在线视频| 国产高清videossex| 欧美久久黑人一区二区| 亚洲成人手机| 成年版毛片免费区| 亚洲三区欧美一区| 女人被躁到高潮嗷嗷叫费观| 亚洲国产毛片av蜜桃av| 91麻豆精品激情在线观看国产 | 在线观看日韩欧美| e午夜精品久久久久久久| 法律面前人人平等表现在哪些方面| 久久热在线av| 男男h啪啪无遮挡| 国产精品国产高清国产av | 亚洲国产精品一区二区三区在线| 这个男人来自地球电影免费观看| 久久久国产成人免费| 少妇的丰满在线观看| 国产精品一区二区在线不卡| 窝窝影院91人妻| 中文字幕精品免费在线观看视频| 亚洲三区欧美一区| 日本五十路高清| 在线观看免费视频网站a站| 中文字幕人妻丝袜一区二区| 91av网站免费观看| 中国美女看黄片| 日本一区二区免费在线视频| 成熟少妇高潮喷水视频| xxxhd国产人妻xxx| 久久草成人影院| 最近最新中文字幕大全电影3 | 亚洲国产精品一区二区三区在线| 成年人黄色毛片网站| 久久久久视频综合| 最近最新中文字幕大全电影3 | 超色免费av| 性少妇av在线| 最新美女视频免费是黄的| 一级毛片高清免费大全| 九色亚洲精品在线播放| 午夜福利乱码中文字幕| 亚洲人成77777在线视频| 久久久久国产一级毛片高清牌| 免费在线观看视频国产中文字幕亚洲| 一区福利在线观看| 日韩欧美免费精品| 国产区一区二久久| 夜夜躁狠狠躁天天躁| 999久久久国产精品视频| av有码第一页| 成年女人毛片免费观看观看9 | 亚洲中文字幕日韩| 波多野结衣av一区二区av| 老汉色av国产亚洲站长工具| 精品福利永久在线观看| 国产麻豆69| 高潮久久久久久久久久久不卡| 激情在线观看视频在线高清 | xxx96com| 午夜福利视频在线观看免费| 黄片大片在线免费观看| 亚洲av成人一区二区三| 999久久久国产精品视频| 久久久精品免费免费高清| 天天添夜夜摸| 中文欧美无线码| 美女扒开内裤让男人捅视频| 亚洲成人手机| 曰老女人黄片| 天天躁夜夜躁狠狠躁躁| 国产精品免费一区二区三区在线 | 国产黄色免费在线视频| 最新在线观看一区二区三区| 国产99久久九九免费精品| 女性被躁到高潮视频| 欧美+亚洲+日韩+国产| 亚洲男人天堂网一区| 午夜亚洲福利在线播放| 久9热在线精品视频| 亚洲精品国产色婷婷电影| 成人永久免费在线观看视频| 欧美日韩亚洲高清精品| 亚洲视频免费观看视频| 欧美日韩乱码在线| 99精品久久久久人妻精品| av一本久久久久| 色老头精品视频在线观看| 午夜免费成人在线视频| 一二三四社区在线视频社区8| a级毛片在线看网站| 国产精品亚洲av一区麻豆| 亚洲精品久久午夜乱码| 亚洲五月色婷婷综合| 精品国产一区二区三区四区第35| 亚洲人成77777在线视频| 午夜精品在线福利| 亚洲欧洲精品一区二区精品久久久| 欧美性长视频在线观看| 亚洲av成人不卡在线观看播放网| 99re6热这里在线精品视频| 国产精品久久视频播放| 老司机福利观看| 高清欧美精品videossex| 黑人巨大精品欧美一区二区蜜桃| 亚洲,欧美精品.| 久久久久久久久久久久大奶| 国产97色在线日韩免费| 窝窝影院91人妻| 精品国产亚洲在线| 人妻 亚洲 视频| 天堂中文最新版在线下载| 免费不卡黄色视频| 精品卡一卡二卡四卡免费| 欧美亚洲日本最大视频资源| 久久精品国产亚洲av香蕉五月 | 国产精品一区二区免费欧美| 欧美日韩精品网址| 国产又色又爽无遮挡免费看| 香蕉丝袜av| 美女 人体艺术 gogo| 亚洲精品av麻豆狂野| 国产精品久久久久久精品古装| 国产精品国产av在线观看| cao死你这个sao货| 亚洲第一欧美日韩一区二区三区| 亚洲av成人一区二区三| 久久人人97超碰香蕉20202| www.999成人在线观看| 欧美成狂野欧美在线观看| 9色porny在线观看| 亚洲专区国产一区二区| av在线播放免费不卡| 久久久久久久精品吃奶| 少妇的丰满在线观看| 日韩免费高清中文字幕av| 国产野战对白在线观看| 老司机午夜福利在线观看视频| 久久久久久久久免费视频了| 777久久人妻少妇嫩草av网站| 欧美在线黄色| 亚洲av日韩在线播放| 亚洲熟妇中文字幕五十中出 | 欧美日韩乱码在线| 亚洲精品乱久久久久久| 黑人巨大精品欧美一区二区mp4| 国产av精品麻豆| av天堂久久9| 天天影视国产精品| 国产色视频综合| 真人做人爱边吃奶动态| 精品人妻1区二区| 日韩视频一区二区在线观看| 日韩一卡2卡3卡4卡2021年| 久久国产亚洲av麻豆专区| 女人被躁到高潮嗷嗷叫费观| 亚洲精品美女久久av网站| 制服诱惑二区| 国产精品电影一区二区三区 | 国产成人精品无人区| 成人国语在线视频| 久久精品亚洲熟妇少妇任你| 搡老岳熟女国产| 免费人成视频x8x8入口观看| 午夜成年电影在线免费观看| 777久久人妻少妇嫩草av网站| 在线观看免费视频网站a站| a级毛片在线看网站| 法律面前人人平等表现在哪些方面| 国产精品99久久99久久久不卡| 黄色女人牲交| 黄片大片在线免费观看| 日日爽夜夜爽网站| 国产成人欧美| 亚洲精品国产精品久久久不卡| 99热国产这里只有精品6| 成年动漫av网址| 两个人免费观看高清视频| 18在线观看网站| 黄片播放在线免费| 纯流量卡能插随身wifi吗| 日韩熟女老妇一区二区性免费视频| 99久久国产精品久久久| 香蕉久久夜色| 国产又爽黄色视频| 国产成人精品无人区| 国产精品欧美亚洲77777| 一区二区三区激情视频| 十八禁网站免费在线| 99香蕉大伊视频| 午夜91福利影院| www.999成人在线观看| 国产精品 欧美亚洲| 天天躁日日躁夜夜躁夜夜| 亚洲精品国产区一区二| 亚洲中文av在线| 国产精品秋霞免费鲁丝片| 亚洲av成人一区二区三| 久久人人97超碰香蕉20202| 国产一区二区三区在线臀色熟女 | 成人手机av| 少妇猛男粗大的猛烈进出视频| 日本五十路高清| 高清黄色对白视频在线免费看| 黄色丝袜av网址大全| 婷婷成人精品国产| 国产成人精品在线电影| 亚洲精品乱久久久久久| 水蜜桃什么品种好| 深夜精品福利| 亚洲人成伊人成综合网2020| 不卡av一区二区三区| 国产蜜桃级精品一区二区三区 | 九色亚洲精品在线播放| 美女高潮喷水抽搐中文字幕| 国产精品美女特级片免费视频播放器 | 亚洲黑人精品在线| 久久国产精品人妻蜜桃| 大型黄色视频在线免费观看| 91av网站免费观看| 高清在线国产一区| 午夜视频精品福利| 国产亚洲精品久久久久5区| 成人18禁在线播放| 亚洲国产欧美日韩在线播放| 亚洲人成77777在线视频| 777米奇影视久久| 亚洲成人免费电影在线观看| 欧美日韩中文字幕国产精品一区二区三区 | 69精品国产乱码久久久| 91九色精品人成在线观看| 久久狼人影院| 午夜精品在线福利| 天天躁日日躁夜夜躁夜夜| 久久亚洲精品不卡| 欧美色视频一区免费| 好看av亚洲va欧美ⅴa在| av视频免费观看在线观看| av福利片在线| 欧美精品啪啪一区二区三区| 午夜福利,免费看| 操美女的视频在线观看| 亚洲色图av天堂| 日韩人妻精品一区2区三区| 国产精品 欧美亚洲| 国产高清视频在线播放一区| 少妇裸体淫交视频免费看高清 | 麻豆乱淫一区二区| 久久精品人人爽人人爽视色| 亚洲五月天丁香| 国精品久久久久久国模美| 国产成人系列免费观看| 国产精华一区二区三区| 精品久久久精品久久久| 国产精品久久久人人做人人爽| 99热国产这里只有精品6| 成年人午夜在线观看视频| 亚洲av成人av| 精品午夜福利视频在线观看一区| 国产99白浆流出| 午夜亚洲福利在线播放| 久久人人爽av亚洲精品天堂| 精品久久久久久,| 久久九九热精品免费| 无限看片的www在线观看| 在线免费观看的www视频| 夜夜夜夜夜久久久久| 亚洲成人免费电影在线观看| 黄色视频,在线免费观看| 国产高清国产精品国产三级| 十八禁高潮呻吟视频| a在线观看视频网站| 国产亚洲精品一区二区www | 校园春色视频在线观看| 每晚都被弄得嗷嗷叫到高潮| 最近最新中文字幕大全免费视频| av国产精品久久久久影院| 亚洲国产看品久久| 免费女性裸体啪啪无遮挡网站| 精品卡一卡二卡四卡免费| 丝袜美腿诱惑在线| 精品高清国产在线一区| 久久久久精品人妻al黑| 成人18禁在线播放| 亚洲成人免费av在线播放| 国产区一区二久久| 美女午夜性视频免费| 法律面前人人平等表现在哪些方面| 国产又色又爽无遮挡免费看| 国产精品秋霞免费鲁丝片| 欧美日韩黄片免| 一级,二级,三级黄色视频| 老司机深夜福利视频在线观看| 国产精品.久久久| 黄片播放在线免费| 两个人免费观看高清视频| 少妇的丰满在线观看| 黑人巨大精品欧美一区二区蜜桃| 中文欧美无线码| 久热爱精品视频在线9| 亚洲欧美一区二区三区黑人| 中文字幕高清在线视频| 亚洲熟妇中文字幕五十中出 | 伦理电影免费视频| 99re在线观看精品视频| 日韩一卡2卡3卡4卡2021年| 韩国精品一区二区三区| 免费不卡黄色视频| 免费黄频网站在线观看国产| 亚洲成a人片在线一区二区| 国产精品1区2区在线观看. | 免费在线观看亚洲国产| 国产欧美日韩一区二区三区在线| 黄片大片在线免费观看| 黄色成人免费大全| 天天操日日干夜夜撸| 亚洲自偷自拍图片 自拍| 日韩视频一区二区在线观看| 丁香六月欧美| 久久亚洲精品不卡| 一区在线观看完整版| 欧美成人午夜精品| 亚洲一码二码三码区别大吗| 亚洲自偷自拍图片 自拍| 久久精品人人爽人人爽视色| 欧美成人免费av一区二区三区 | 亚洲片人在线观看| 一区在线观看完整版| 老司机在亚洲福利影院| 国产成人精品无人区| 热99国产精品久久久久久7| 大陆偷拍与自拍| 欧美日韩国产mv在线观看视频| 人人妻人人澡人人爽人人夜夜| 国产1区2区3区精品| 国产一区二区激情短视频| av国产精品久久久久影院| 精品人妻熟女毛片av久久网站| 亚洲在线自拍视频| 欧美黑人欧美精品刺激| 欧美久久黑人一区二区| 欧美黄色片欧美黄色片| 精品少妇一区二区三区视频日本电影| 欧美在线一区亚洲| 手机成人av网站| 狠狠狠狠99中文字幕| 99国产精品一区二区三区| 午夜亚洲福利在线播放| av电影中文网址| 中文字幕人妻丝袜制服| 欧美 亚洲 国产 日韩一| 一夜夜www| www日本在线高清视频| 亚洲av日韩在线播放| 成年人午夜在线观看视频| 男女下面插进去视频免费观看| 在线十欧美十亚洲十日本专区| 这个男人来自地球电影免费观看| 一二三四在线观看免费中文在| 国产精品成人在线| 国产深夜福利视频在线观看| 十分钟在线观看高清视频www| 国产高清激情床上av| 欧美久久黑人一区二区| 国产精品.久久久| 不卡av一区二区三区| 久久精品成人免费网站| 建设人人有责人人尽责人人享有的| 亚洲一卡2卡3卡4卡5卡精品中文| 99国产极品粉嫩在线观看| 精品午夜福利视频在线观看一区| 一本大道久久a久久精品| 国产成人系列免费观看| 99精品在免费线老司机午夜| 色老头精品视频在线观看| 免费黄频网站在线观看国产| 精品免费久久久久久久清纯 | 99国产精品一区二区三区| 一区二区日韩欧美中文字幕| 十八禁人妻一区二区| 国产成人免费无遮挡视频| 日日夜夜操网爽| 无遮挡黄片免费观看| 最新的欧美精品一区二区| 久久人妻av系列| 人人妻,人人澡人人爽秒播| 性色av乱码一区二区三区2| 国产高清国产精品国产三级| 国产99白浆流出| 91成年电影在线观看| 亚洲精品国产一区二区精华液| 一边摸一边做爽爽视频免费| 国产欧美日韩精品亚洲av| 男女高潮啪啪啪动态图| 中文字幕制服av| 亚洲精品中文字幕一二三四区|